From the authors
We read with great interest the article by Wijnant et al.  in a recent issue of European Respiratory Journal investigating the longitudinal outcomes of patients with preserved ratio impaired spirometry (PRISm) in the Rotterdam cohort. PRISm is a subject of increased investigation as it is associated with respiratory symptoms, cardiovascular disease, metabolic syndrome and, quite clearly in the recent study, increased mortality [1–3]. While there have been numerous studies examining outcomes related to PRISm in high-income countries (HICs), few studies have assessed the clinical significance of this spirometric finding in low- and middle-income countries (LMICs).
|Persistent URL||dx.doi.org/10.1183/13993003.00184-2020, hdl.handle.net/1765/130167|
|Journal||The European Respiratory Journal|
Wijnant, S.R.A. (Sara R.A.), Lahousse, L, & Brusselle, G.G. (2020). From the authors. The European Respiratory Journal, 55(4). doi:10.1183/13993003.00184-2020